Aberdeen Asset Management’s Pfizer PFE Stock Holding History

Aberdeen Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$181M	Buy	5,678,676 +367,601	+7%	+$11.6M	0.6%	32
2017 Q1	$172M	Buy	5,311,075 +112,454	+2%	+$3.55M	0.61%	33
2016 Q4	$160M	Sell	5,198,621 -114,029	-2%	-$3.48M	0.61%	32
2016 Q3	$171M	Sell	5,312,650 -76,503	-1%	-$2.56M	0.61%	32
2016 Q2	$180M	Sell	5,389,153 -340,097	-6%	-$10.9M	0.67%	31
2016 Q1	$161M	Sell	5,729,250 -202,684	-3%	-$5.79M	0.58%	32
2015 Q4	$188M	Sell	5,931,934 -494,218	-8%	-$15.5M	0.64%	30
2015 Q3	$192M	Sell	6,426,152 -221,536	-3%	-$7.1M	0.65%	31
2015 Q2	$211M	Sell	6,647,688 -384,286	-5%	-$12.5M	0.61%	30
2015 Q1	$232M	Sell	7,031,974 -441,220	-6%	-$14M	0.62%	30
2014 Q4	$221M	Sell	7,473,194 -991,279	-12%	-$28.4M	0.55%	30
2014 Q3	$237M	Sell	8,464,473 -587,873	-6%	-$16.5M	0.52%	31
2014 Q2	$255M	Buy	9,052,346 +3,951,376	+77%	+$113M	0.53%	31
2014 Q1	$154M	Sell	5,100,970 -225,218	-4%	-$6.72M	0.43%	28
2013 Q4	$154M	Buy	5,326,188 +167,860	+3%	+$4.89M	0.43%	28
2013 Q3	$141M	Buy	5,158,328 +1,597,831	+45%	+$43.5M	0.4%	26
2013 Q2	$94.7M	Buy	+3,560,497	New	+$98.4M	0.3%	27

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aberdeen Asset Management's PFE Position: Q2 2017 in Review

Aberdeen Asset Management increased its Pfizer (PFE) stake by 6.9% in Q2 2017, buying an estimated $11.6M and bringing the position to 5,678,676 shares worth $181M. The position accounts for 0.6% of the portfolio, ranked #32.

Aberdeen Asset Management first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $255M in Q2 2014. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Aberdeen Asset Management held 5,678,676 shares of Pfizer worth $181M as of Q2 2017.
Aberdeen Asset Management bought 367,601 Pfizer shares in Q2 2017, an estimated $11.6M.
Pfizer made up 0.6% of Aberdeen Asset Management's portfolio in Q2 2017, its #32 holding.
Aberdeen Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
Aberdeen Asset Management's Pfizer position peaked at $255M in Q2 2014.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.